Myomo Inc - Asset Resilience Ratio
Myomo Inc (MYO) has an Asset Resilience Ratio of 11.70% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read MYO liabilities breakdown for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2025)
This chart shows how Myomo Inc's Asset Resilience Ratio has changed over time. See MYO net assets for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Myomo Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Myomo Inc (MYO) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $4.30 Million | 11.7% |
| Total Liquid Assets | $4.30 Million | 11.70% |
Asset Resilience Insights
- Moderate Liquidity: Myomo Inc has 11.70% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Myomo Inc Industry Peers by Asset Resilience Ratio
Compare Myomo Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
GN Store Nord
CO:GN |
Medical Devices | -4.56% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 50.79% |
|
Sino Medical Sciences Technology In
SHG:688108 |
Medical Devices | 0.66% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298 |
Medical Devices | 2.82% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 6.89% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
|
T&R Biofab Co. Ltd
KQ:246710 |
Medical Devices | 0.12% |
Annual Asset Resilience Ratio for Myomo Inc (2016–2025)
The table below shows the annual Asset Resilience Ratio data for Myomo Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 47.61% | $18.39 Million | $38.64 Million | -11.25pp |
| 2024-12-31 | 58.86% | $24.87 Million | $42.24 Million | -1.94pp |
| 2023-12-31 | 60.80% | $8.87 Million | $14.58 Million | +8.20pp |
| 2022-12-31 | 52.61% | $5.35 Million | $10.16 Million | -24.65pp |
| 2021-12-31 | 77.25% | $15.52 Million | $20.10 Million | -5.97pp |
| 2020-12-31 | 83.22% | $12.24 Million | $14.71 Million | +15.55pp |
| 2019-12-31 | 67.67% | $4.47 Million | $6.60 Million | -11.31pp |
| 2018-12-31 | 78.98% | $6.54 Million | $8.28 Million | -13.75pp |
| 2017-12-31 | 92.73% | $12.96 Million | $13.97 Million | +44.66pp |
| 2016-12-31 | 48.07% | $797.17K | $1.66 Million | -- |
About Myomo Inc
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.… Read more